14th Annual Pacific Psychopharmacology Conference

14th Annual Pacific Psychopharmacology Conference


Target Audience:

Psychiatrists, Primary Care Physicians, Pharmacists, Psychologists, Nurse Practitioners, Psychiatric Nurses, and Social Workers

Course Format: Full-day of plenary talks highlighted by interactive Q&A time.
  • Sep 25, 2020
Broadcast starts: 0800 PDT

Online from Vancouver
Full-Sized Map


Join us for our most impressive line-up of speakers ever, all from the comfort of your office or home.

Our usual in-person conference will be going completely virtual this year and will feature international experts on depression, anxiety, schizophrenia, and evolving approaches to the psychiatric impacts of COVID-19. And as always, we will offer local expertise on other important topics in psychopharmacology. Participants will be able to interact with the speakers via a live Q&A board, with lots of time for audience questions. We look forward to seeing you online this fall!

 Join the conversation online: #PPPC2020 



Learning objectives will be added/updated as they are received.

0800 - 0805 Welcome and Opening Remarks Dr. Randall White

0805 - 0845
0845 - 0900

Systematic Review of Efficacy and Safety of Antidepressants
Q&A Session  

Dr. Andrea Cipriani

0900 - 0940
0940 - 0955

The Role of Esketamine and Emerging Rapid Acting Antidepressants
Q&A Session

Dr. Roger McIntyre

0955 - 1035
1035 - 1050

Antipsychotic Therapy
Q&A Session

At the end of this presentation, participants will:

  1. Be familiar with current guidelines for the identification of treatment resistance Schizophrenia
  2. Have an up to date perspective on the indications for clozapine treatment in Schizophrenia
  3. Have a better sense of the risks benefits associated with the clozapine treatment
Dr. John Kane

1050 - 1100

AM Break

1100 - 1130
1130 - 1145
Anxiety, Depression and Neuropsychiatric Disorders in Older Adults
Q&A Session
Dr. Zahinoor Ismail
1145 - 1215
1215 - 1230
Evaluation and Treatment of Hospitalized Patients with CoVID-19
Q&A Session
Dr. Damir Huremovic

1230 - 1300

Lunch Break


A)  Don’t Worry, You’ve Got This! Management of Pediatric Anxiety Disorders

At the end of this presentation, participants will be able to:

  1. Choose the optimal pharmacotherapeutic approach to pediatric anxiety disorders from available treatment options.
  2. Contrast the benefits and risks of medications (e.g. SSRIs, SNRIs) when prescribed for pediatric anxiety disorders versus when prescribed for pediatric depressive disorders.
Dr. Dean Elbe
  B)  Post CoVID-19 Psychiatric Outcomes   Dr. Damir Huremovic 

C)  When Meth and Psychosis Come Together​

At the end of this presentation, participants will be able to:

  1. Describe the relationship between methamphetamine use and psychotic symptoms/disorders.
  2. Review the current evidence on the efficacy of prescribed psychostimulant substitution.
  3. Discuss the complexities of safe supply of stimulants in patients with psychosis.
Dr. Julius Elefante
Mr. Reza Rafizadeh

1345 - 1400

PM Break


D)  Substance Use Disorders through an Occupational Lens

At the end of this presentation, participants will have:

  1. Enhanced knowledge of the occupational impact of substances/medications
  2. Increased skills in applying a practical instrument to classify substances/medications as it relates to the impact on occupational capacity, risk, and tolerance
  3. Augmented confidence in applying workplace guidelines related to the consumption of cannabis
Dr. Charl Els
  E)  Vaping and E-cigarettes Dr. Milan Khara
  F)  Buprenorphine as a Monthly Long-Acting Injection    Dr. Nader Sharifi
Dr. Tamara Mihic
1445 - 1450 Quick Break  
1450 - 1520
1520 - 1535

Alcohol Use Disorder Guidelines
Q&A Session

At the end of this presentation, participants will be able to:

    1. Discuss the new standard of care and provincial guidelines for people with AUD
    2. Determine what issues may be keeping people from accessing evidence-based AUD care
    3. Develop greater compassion and hope for people with AUD and become a champion for this new standard of care
    Dr. Christy Sutherland
    1535 - 1540 Closing Remarks Dr. Jacky Siu


    Key Speakers

    Andrea Cipriani, MD, PhD

    Professor of Psychiatry, NIHR Research Professor; Director, Clinical Research Facility, Warneford Hospital, Oxford; Associate Director, R&D, Oxford Health NHS Foundation Trust, Oxford

    John Kane, MD

    Chairman of Psychiatry, Zucker Hillside Hospital, NY; Chairman, Psychiatry and Professor of Psychiatry & Molecular Medicine, Hofstra North Shore-LIJ School of Medicine

    Roger McIntyre, MD FRCPC

    Professor of Psychiatry and Pharmacology, University of Toronto; Head, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto; Executive Director, Brain and Cognition Discovery Foundation, Toronto

    Zahinoor Ismail, MD FRCPC

    Associate Professor, Community Health Sciences, Psychiatry, Hotchkiss Brain Institute, University of Calgary; Principal Investigator, Ron & Rene Ward Centre for Healthy Brain Aging Research

    Damir Huremovic, MD, MPP

    Assistant Professor, Donald & Barbara Zucker School of Medicine, Hofstra/Northwell; Psychiatrist, Nassau University Medical Center East Meadow, NY




    Early bird registration: Mon. Aug 17, 2020 | Add to calendar +

      By AUG 17 After AUG 17
    Delegates $225 $250
    Residents & Students $50 $75


    All fees are in Canadian dollars. Fees are subject to 5% GST.

    Fees include: access to the live virtual event, all available materials, and access to the post-event recording.

    Cancellations and Refunds

    You May Also Like

    Target Audience:

    Members, Psychiatrists, residents & students

    Date: Nov 21, 2020
    Online from Vancouver  British Columbia
    Target Audience:

    Family physicians, occupational physicians, specialty physicians, physiotherapists, psychiatrists, registered nurses, nurse practitioners, residents & students

    Date: Dec 5, 2020
    Online from Vancouver  British Columbia
    More »